Studies found that prostate cancer gene expression marker 1 (PCGEM1) with highly prostate-specificity was also related to androgen receptor (AR) signaling and was overexpressed in therapy-resistant PCa [23, 24]. The gene discussed is PCGEM1; the disease is posterior cortical atrophy.